# Peoples Bancorp of North Carolina Inc: overview PEBK · Nasdaq · CIK 1093672 · [Financials](/sectors/financials.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/pebk.md) · [Financials](/companies/pebk/financials.md) · [Filings](/companies/pebk/filings.md) · [Insiders](/companies/pebk/insiders.md) Latest reported revenue: [$4.7m](/filings/0001654954-21-008476.md) for Q2 FY2020, three months to 2020-06-30, from the 10-Q filed Aug 4, 2021 (XBRL us-gaap:Revenues, accession 0001654954-21-008476). ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $k | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.72](/filings/0001654954-25-012570.md) | not reported | [0.79](/filings/0001654954-26-004543.md) | [0.95](/filings/0001654954-26-007234.md) | [0.67](/filings/0001654954-25-012570.md) | not reported | [0.80](/filings/0001654954-26-004543.md) | [0.96](/filings/0001654954-26-007234.md) | | Free cash flow | $k | [4,686 d](/filings/0001654954-25-012570.md) | [5,173 d](/filings/0001654954-26-002154.md) | [5,161](/filings/0001654954-26-004543.md) | [5,368 d](/filings/0001654954-26-007234.md) | [4,374 d](/filings/0001654954-25-012570.md) | [5,057 d](/filings/0001654954-26-002154.md) | [4,580](/filings/0001654954-26-004543.md) | [6,039 d](/filings/0001654954-26-007234.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $m | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [2.63](/filings/0001654954-24-002793.md) | [2.85](/filings/0001654954-25-002689.md) | [2.77](/filings/0001654954-25-002689.md) | [2.98](/filings/0001654954-26-002154.md) | [3.62](/filings/0001654954-26-002154.md) | | Free cash flow | $m | [26.4](/filings/0001654954-24-002793.md) | [18.1](/filings/0001654954-25-002689.md) | [20.8](/filings/0001654954-25-002689.md) | [20.0](/filings/0001654954-26-002154.md) | [20.0](/filings/0001654954-26-002154.md) | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/pebk/insiders.md) | Date | Insider | Role | Transaction | Shares | Reported price | Value | Filing | | --- | --- | --- | --- | ---: | ---: | ---: | --- | | 2026-10-29 | [Abernethy James S](/insiders/1244172.md) | Director | Sale (S) | 600 | $43.93 | $26.4k | [Form 4](/filings/0001654954-26-009235.md) | | 2026-10-28 | [Abernethy James S](/insiders/1244172.md) | Director | Sale (S) | 1,000 | $43.79 | $43.8k | [Form 4](/filings/0001654954-26-009235.md) | | 2026-10-21 | [Price Billy L JR DR](/insiders/1284378.md) | Director | Purchase (P) | 200 | $42.285 | $8.5k | [Form 4](/filings/0001654954-26-009146.md) | ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [WELLINGTON MANAGEMENT GROUP LLP](/funds/902219.md) | 2026-06-30 | $18.0m | 416,584 | | Reduced −2,024 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $13.4m | 311,532 | | Added +21,659 | | [GENDELL JEFFREY L](/funds/1056581.md) | 2026-06-30 | $9.4m | 217,763 | | Unchanged | | [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $8.6m | 199,237 | | Reduced −29,769 | | [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $8.0m | 186,063 | | Added +18,780 | | [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $5.1m | 117,517 | | Added +11,261 | | [BRIDGEWAY CAPITAL MANAGEMENT, LLC](/funds/1107261.md) | 2026-06-30 | $3.6m | 83,863 | | Added +2,731 | | [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $3.3m | 77,656 | | Added +46,792 | | [ARROWSTREET CAPITAL, LIMITED PARTNERSHIP](/funds/1164508.md) | 2026-06-30 | $3.3m | 77,089 | | Added +16,237 | | [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $2.8m | 64,326 | | Added +9,546 | ## Recent filings [All 753 filings](/companies/pebk/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-10-19 | 10:06 ET | [8-K](/filings/0001654954-26-009034.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-009034 | | 2026-08-04 | 11:06 ET | [10-Q](/filings/0001654954-26-007234.md) | Quarterly report, period 2026-06-30 | 0001654954-26-007234 | | 2026-07-21 | 11:04 ET | [8-K](/filings/0001654954-26-006769.md) | 5.02 Departure or appointment of officers or directors | 0001654954-26-006769 | | 2026-07-20 | 09:30 ET | [8-K](/filings/0001654954-26-006729.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-006729 | | 2026-05-08 | 09:06 ET | [8-K](/filings/0001654954-26-004580.md) | 5.07 Shareholder vote results | 0001654954-26-004580 | | 2026-05-07 | 16:31 ET | [10-Q](/filings/0001654954-26-004543.md) | Quarterly report, period 2026-03-31 | 0001654954-26-004543 | | 2026-04-20 | 09:37 ET | [8-K](/filings/0001654954-26-003709.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-003709 | | 2026-03-25 | 10:16 ET | [DEF 14A](/filings/0001654954-26-002731.md) | Proxy statement, period 2026-03-25 | 0001654954-26-002731 | | 2026-03-11 | 15:39 ET | [10-K](/filings/0001654954-26-002154.md) | Annual report, period 2025-12-31 | 0001654954-26-002154 | | 2026-01-26 | 09:46 ET | [8-K](/filings/0001654954-26-000585.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001654954-26-000585 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001654954-26-002154.md), filed Mar 11, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1093672 - Tickers: PEBK - Exchange: Nasdaq - SIC code: 6022 State Commercial Banks - State of incorporation: NC - Filer category: Accelerated filer
Smaller reporting company Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 15:31 ET. No prices; not investment advice.